2017 Special Call for Pilot and Feasibility

 

SPECIAL CALL FOR INNOVATIVE AND COLLABORATIVE PILOT AND FEASIBILITY STUDIES (PFS) FOR 2017

LETTER OF INTENT DEADLINE APRIL 10, 2017  (CLOSED)

APPLICATION DEADLINE MAY 19, 2017

The CURE: Digestive Diseases Research Center invites applications for highly innovative proposals in the field of gastroenterology preferentially involving the collaboration between two investigators. Proposed projects need to be of relevance to the overall CURE Research Program in gastrointestinal biology and neurogastroenterology, with special emphasis on receptor and signal transduction mechanisms, brain-gut interactions, molecular and integrative physiology, and mechanisms underlying diseases of the digestive system. The ultimate goal of the PFS program is to give the opportunity to the applicants to test novel and innovative hypotheses preferentially based on collaborative effort and generate sufficient data for the submission of an NIH grant, Merit Review or related agency research support.  Funding level awarded is $30,000 per one year.

ELIGIBILITY:

1.  New investigators without current or past NIH or related agency research support as principal     investigators, who are seeking to establish their own independent research program

2.  Established investigators with other research support, who have not been involved in gastrointestinal research and who want to enter this field of research.

3.  Established investigators with other support for gastrointestinal research, who want to pursue a new research direction in the field of gastroenterology, which represents a significant departure from their past or current funded research.

 

AWARD TERMS:

  1. Applicants must hold a Ph.D., M.D. or equivalent degree and have at least 3 years of postgraduate research experience.
  2. Trainees who are recipient of an NRSA individual award (F32) or are supported by an institutional training grant (T32), or fellowship are eligible in their last year of training.
  3. Applicants must have a UCLA appointment in an academic track (research fellows or postdoctoral scholars are included) by the time of the award.
  4. New investigators without independent support need to provide documentation of support (i.e. space available and financial support beyond the PFS fund) of a UCLA or VA faculty sponsor.
  5. Applicants are required to use at least one Center core in addition to the Administrative Core (see website for list of Cores and services at http://www.cure.med.ucla.edu) and must perform research at CURE (VA or UCLA) and/or UCLA.
  6. Applications establishing collaborative interactions within the Center are encouraged.

APPLICATION PROCESS:

LETTER of INTENT: A one-page letter of intent and the applicant’s NIH-style bio sketch should be submitted by April 10, 2017 as e-mail attachment to the program coordinator, Jacqueline Ismen (JIsmen@mednet.ucla.edu). The letter of intent should include 1) the applicant name, rank and affiliation, 2) the proposal title, 3) the hypothesis and a short paragraph describing the salient features of the project, 4) which core(s) of the CURE: DDRC will be used, 5) the mentor’s funded research project(s), if the applicant is a junior investigator without independent funding, or of other funded project(s), if the applicant is a senior investigator, and 6) how the proposed project will differ from the funded projects. The letter of intent (no more than one page in length) and the NIH bio sketch must be submitted as a single pdf document. Documents not conforming will be returned. Applicants will be notified of their eligibility to submit a full application. The template for the letter of intent and instructions for full applications can be found on the CURE:DDRCC website http://www.cure.med.ucla.edu).

FULL APPLICATION DEADLINE:  Full Application Deadline: May 19, 2017; Starting Date: July 1, 2017